In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 (Listing Regulations) we wish to inform that based on the recommendation of the Nomination and Remuneration Committee, the Board considered and approved:1. Appointment of Mr. Dipesh Vaidya (DIN: 10816986) as an Additional Independent Director :2. Appointment of Mr. Mansoor Vahab (DIN:02882381) as an Additional Non Executive Director :
Remedium Lifecare - Intimation Of Appointment Of Directors
Filed with BSE · · 4 pages · English
Release
Earlier from Supha Pharmachem
Later from Supha Pharmachem
- Board Meeting Outcome for For Meeting Held On Thursday, November 14, 2024.
- Results For The Quarter And Half Year Ended September 30, 2024.
- Supha Pharmachem Ltd Press Release Nov 14 2024
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- Supha Pharmachem Ltd Press Release Dec 23 2024
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem